Redwire Appoints Mike Gold as President of Civil and International Space Business to Lead Global Expansion

Redwire Appoints Mike Gold as President of Civil and International Space Business to Lead Global Expansion

JACKSONVILLE, Fla.–(BUSINESS WIRE)–
Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next-generation space economy, today announced that Mike Gold has been appointed President of Civil and International Space business.

This key appointment emphasizes the company’s focus on scaling global growth and accessing additional international market sectors. Redwire recently expanded its European footprint by opening a new office in Warsaw, Poland. With institutional space budgets (civil and defense) across global spacefaring nations collectively reaching record highs in recent years and the European Space Agency (ESA) committed to ensuring sustainable growth in the European space sector, Redwire is well positioned to grow its civil and international business.

“We are very pleased to appoint Mike to this new role within the company as we continue to scale our business internationally. Mike is a well-known space leader with the international experience and global relationships to meet our strategic goals,” said Peter Cannito, Redwire Chairman and CEO. “With a significant international presence and proven performance on orbit with multiple Proba satellites and other critical European programs, Redwire is well positioned for global growth under Mike’s leadership.”

About Mike Gold

Prior to joining Redwire, Gold was NASA’s Associate Administrator for Space Policy and Partnerships, Acting Associate Administrator for the Office of International and Interagency Relations, and Senior Advisor to the Administrator for International and Legal Affairs. Gold was awarded NASA’s Outstanding Leadership Medal in recognition for his achievements while at NASA including the Artemis Accords, the Gateway MOUs, and regulatory reforms. Before joining NASA, Gold was Vice President of Civil Space at Maxar Technologies, General Counsel for the company’s legacy Radiant Solutions business unit, and Vice President of Washington Operations and Business Development. Gold also spent 13 years at Bigelow Aerospace where he established the company’s Washington office, oversaw the launches of the Genesis 1 and 2 spacecraft, and was a recipient of a NASA Group Achievement award for the development and deployment of the Bigelow Expandable Activity Module (BEAM) on the International Space Station. Additionally, Gold received the International Astronautical Federation’s 2024 Excellence in International Cooperation Award, a 2025 Aviation Week Laureate Award for the Artemis Accords, and a 2024 NASA Silver Group Achievement Award for his role on the agency’s UAP Independent Study Team. Gold has served as Chair of the Department of Transportation’s Commercial Space Transportation Advisory Committee, Chair of the NASA Advisory Committee’s Regulatory and Policy Committee, and was a member of the National Academies Space Technology Industry-Government-University Roundtable. Gold has authored numerous law review articles and editorials addressing commercial space issues. He has also testified on many occasions before the U.S. House of Representatives and the U.S. Senate as an expert in commercial space as well as space law and policy. Gold received a BA from Brandeis University and a JD from the University of Pennsylvania Law School.

About Redwire

Redwire Corporation (NYSE: RDW) is a global space infrastructure and innovation company enabling civil, commercial, and national security programs. Redwire’s proven and reliable capabilities include avionics, sensors, power solutions, critical structures, mechanisms, radio frequency systems, platforms, missions, and microgravity payloads. Redwire combines decades of flight heritage and proven experience with an agile and innovative culture. Redwire’s approximately 750 employees working from 17 facilities located throughout the United States and Europe are committed to building a bold future in space for humanity, pushing the envelope of discovery and science while creating a better world on Earth. For more information, please visit redwirespace.com.

Media Contact:

Tere Riley

[email protected]

321-831-0134

OR

Investors:

[email protected]

904-425-1431

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS: Satellite Technology Aerospace Manufacturing Other Technology Other Science Science

MEDIA:

Logo
Logo

Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

New Brand Features Premium Genetics, Selected for Potency, Terpenes, and Consistency

SMITHS FALLS, Ontario–(BUSINESS WIRE)–
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Spectrum Reserve, a new premium medical cannabis brand in Canada. Designed to meet the evolving needs of medical cannabis patients, Spectrum Reserve represents the peak of cannabis cultivation – featuring flower selected for size, potency, and terpene levels through rigorous in-house standards during cultivation and post-harvest.

Under this new program, Spectrum Reserve is expected to introduce new strains on a regular basis based on patient needs, preferences, and feedback. The strains which generate the most positive and consistent customer feedback will remain in market, while others will be phased out to make way for new genetics through a process of constant enhancement. This approach will help Spectrum Therapeutics consistently deliver new, premium quality strains to the medical cannabis market in Canada.

“By selecting only the genetics that deliver an elevated combination of THC and terpenes, Spectrum Reserve offers a cannabis experience that evolves through continuous innovation while consistently meeting the needs of medical cannabis patients,” said Andrew Bevan, SVP Medical Sales, Canopy Growth. “This new Spectrum Reserve program reinforces our leadership in medical cannabis by combining industry-leading cultivation with a strong focus on premium quality.”

The first release under the Spectrum Reserve brand features four flower strains, each selected for the combination of their potency and terpene profile:

  1. Power Plant x Super Silver Haze (Indica, 22-25% THC): A rich, woody and earthy aroma, with a sharp, peppery taste and 2.21% total terpenes.
  2. Grape Star x Golden Lemons (Sativa, 22-25% THC): With a dank white grape aroma, this strain features 1.77% total terpenes, offering a smooth, uplifting experience.
  3. Malawi x Kosher Tangie (Hybrid, 27-30% THC): A complex citrus and chocolate flavour profile, complemented by a pungent, earthy aroma, with 2.59% total terpenes.
  4. Raspberry Parfait (Sativa-Dominant Hybrid, 22-27% THC): With 2.59% total terpenes, this strain features a plum, berry, and violet aroma for a rich and flavorful experience.

Patients registered with Spectrum Therapeutics can visit www.spectrumtherapeutics.com to obtain more information on Spectrum Reserve flower strains.

About Canopy Growth

Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives.

Through an unwavering commitment to our consumers, Canopy Growth delivers innovative products with a focus on premium and mainstream cannabis brands including Tweed, 7ACRES, DOJA, Deep Space and Claybourne, as well as category-defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.

Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA. Canopy USA’s portfolio includes ownership of Acreage Holdings, a vertically integrated multi-state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Brands, a leading North American edibles brand, and majority ownership of Jetty Extracts, a California-based producer of high-quality cannabis extracts and clean vape technology.

At Canopy Growth, we’re shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we’re paving the way for a better understanding of all that cannabis can offer.

For more information visit www.canopygrowth.com.

More Information

Alex Thomas

Director, Communications

[email protected]

Investor Contact:

Tyler Burns

Director, Investor Relations

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Alternative Medicine Cannabis Retail Health Specialty Natural Resources

MEDIA:

Logo
Logo

Bowman Awarded $2.2M Contract for ADA Design in Philadelphia

Bowman Awarded $2.2M Contract for ADA Design in Philadelphia

Award marks Bowman’s fifth consecutive ADA-related contract for pedestrian infrastructure enhancements in the city

RESTON, Va.–(BUSINESS WIRE)–
Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services firm, has been awarded a $2.2 million contract to design 1,236 ADA-compliant curb ramps at 355 intersections across the City of Philadelphia. This contract marks the fifth consecutive ADA-related assignment Bowman has undertaken in Philadelphia and aligns with the city’s broader initiative to install 10,000 ADA-compliant curb ramps by April 2038.

Under this new assignment, Bowman will provide comprehensive ADA design services, overseeing the engineering and design of curb ramps in compliance with PennDOT and City of Philadelphia standards, while also conducting right-of-way (ROW) assessments to ensure the designs remain within public property limits. As part of the contract, Bowman’s scope of work includes evaluating existing site conditions, developing alternative ramp configurations as needed, facilitating property owner coordination, addressing historic review requirements and providing ongoing design-related guidance throughout the project.

“Bowman is proud to support Philadelphia’s commitment to accessibility by designing thousands of ADA-compliant curb ramps and transit solutions across the city,” said Gary Bowman, chairman and CEO of Bowman. “Under our previous four contracts, we’ve delivered or are in the process of delivering 3,480 curb ramps at 920 intersections, with a combined value exceeding $5.1 million. Under this new contract and in anticipation of additional ADA ramp contracts expected from the city in the coming years, Bowman is well-positioned to continue enhancing Philadelphia’s pedestrian infrastructure in support of its long-term accessibility goals.”

Bowman’s expertise in ADA-compliant infrastructure extends across the country, supporting municipalities of all sizes in their mission to improve pedestrian accessibility. With a portfolio spanning thousands of curb ramps and transit solutions, Bowman has consistently demonstrated a comprehensive understanding of the challenges and intricacies involved in designing accessible public spaces. As communities nationwide prioritize more inclusive pedestrian networks, Bowman continues to lead the way, delivering practical solutions that enhance mobility for all.

About Bowman Consulting Group Ltd.

Headquartered in Reston, Virginia, Bowman is a national engineering services firm delivering infrastructure, technology and project management solutions to customers who own, develop and maintain the built environment. With over 2,300 employees in more than 100 locations throughout the United States, Bowman provides extensive planning, engineering, geospatial, construction management, commissioning, environmental consulting, land procurement and other technical services to customers operating in a diverse set of regulated end markets. Bowman trades on the Nasdaq under the symbol BWMN. For more information, visit bowman.com or investors.bowman.com.

General Media Contact:

Christina Nichols

[email protected]

Investor Relations Contact:

Betsy Patterson

[email protected]

KEYWORDS: United States North America Pennsylvania Virginia

INDUSTRY KEYWORDS: Engineering Consumer Other Construction & Property Manufacturing Construction & Property Urban Planning People with Disabilities

MEDIA:

Logo
Logo

Aramark’s IN2WORK Job Skills Program Turns 20:Educational Path in Correctional Facilities Has Grown to 32 States, more than 290 Programs, and more than 14,000 Graduates

Aramark’s IN2WORK Job Skills Program Turns 20:

Educational Path in Correctional Facilities Has Grown to 32 States, more than 290 Programs, and more than 14,000 Graduates

PHILADELPHIA–(BUSINESS WIRE)–
Aramark Correctional Services is celebrating the 20th anniversary of its IN2WORK (I2W) program, a milestone in the journey of working with thousands of justice-impacted individuals, offering education and industry certifications for a path to success both during and post-incarceration.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250402392828/en/

Aramark Correctional Services is celebrating the 20th anniversary of its IN2WORK (I2W) program, a milestone in the journey of working with thousands of justice-impacted individuals, offering education and industry certifications for a path to success both during and post-incarceration.

Aramark Correctional Services is celebrating the 20th anniversary of its IN2WORK (I2W) program, a milestone in the journey of working with thousands of justice-impacted individuals, offering education and industry certifications for a path to success both during and post-incarceration.

The opt-in IN2WORK program helps incarcerated people prepare for careers and re-entry into their communities by offering food and warehouse safety training—ServSafe Managers certification from the National Restaurant Association, and a Certified Specialist certificate from the National Retail Federation in Supply Chain, Inventory & Logistics, respectively—through both classroom and hands-on-training, taking a phased approach to learning.

“We are part of the lives of many justice-impacted people every day through our food and commissary operations, which provides us with a unique opportunity to affect change and offer hope of new beginnings,” said Tim Barttrum, President and CEO of Aramark Correctional Services. “We always look for opportunities to make a difference, and IN2WORK does just that, and it has been a privilege to see it grow from a feature we offered to an integral part of our mission.”

IN2WORK had its genesis in 1999 with a goal of providing incarcerated individuals with food safety training and experience working in a team environment. During the program’s first decade, it became more formalized, gained the IN2WORK moniker, and expanded from food to retail and warehousing training. Since its launch, I2W has been implemented in 32 states, with more than 290 programs, and has graduated more than 14,000 students.

Promoting Post Release Success

The goal of I2W is to help incarcerated individuals take control of their lives by giving them the tools, experience, certifications, and confidence they need to support themselves and their families as they transition back to life in their communities. Graduates of the I2W program, as well as their family members, are eligible for Aramark scholarships to help them complete their educational goals. In the last five years, more than $170K has been awarded to graduates and their families.

“There is growing recognition that incarceration alone is not an effective solution to reducing recidivism and that there is power in education and employment for rehabilitation and helping break the cycle of incarceration,” said Nicole McVaugh, Director of the IN2WORK program. “Reentry is a place where small victories can make a big difference. Whether it’s implementing mentorship programs, forging partnerships with community organizations, or expanding job training initiatives, the program expansion and success of our graduates is a priority.”

The Program and Student Evolution

The program has resonated with facility residents, thousands of whom have opted into I2W and using the program as a stepping-stone to their futures. Aramark Correctional Services consistently see results with those who implement the program, including increased self-worth, esteem, and morale among the residents, factors that have been proven to promote a safer environment and more positive outcomes for those who are incarcerated.

“The IN2WORK impact has reached beyond what any of us had every thought it would. The goals in the beginning were simple: provide food safety education to those incarcerated,” said Belinda Peterson, IN2WORK Manager. “Additionally, we listened to the needs of our graduates that have been released, and we realized that job placement was a huge need. Aramark is a Fair Chance company because it’s the right thing to do. We started this path 20 years ago and we provide so much more than a book and a certification. Our IN2WORK program gives hope—hope for a better future for themselves, their families, and their communities.”

About Aramark Correctional Services

Aramark Correctional Services offers efficient, safe, and nutritious hospitality experiences to correctional staff and justice-impacted individuals by providing stellar food and commissary services that contribute to a secure environment. Whether facilitating family connections or teaching essential career skills like warehouse operations, hospitality, and management, Aramark Correctional Services empowers justice-impacted individuals to re-establish their place in society through the IN2WORK® program, providing individuals with skills necessary for successful reintegration. Connect with Correctional Services on LinkedIn to learn more.

About Aramark

Aramark (NYSE: ARMK) proudly serves the world’s leading educational institutions, Fortune 500 companies, world champion sports teams, prominent healthcare providers, iconic destinations and cultural attractions, and numerous municipalities in 16 countries around the world with food and facilities management. Because of our hospitality culture, our employees strive to do great things for each other, our partners, our communities, and the planet. Learn more at www.aramark.com and connect with us on LinkedIn, Facebook, X, and Instagram.

Heather Dotchel, [email protected]

KEYWORDS: United States North America Pennsylvania

INDUSTRY KEYWORDS: Other Retail Professional Services Philanthropy Food/Beverage Other Education Continuing Other Philanthropy Retail Education Other Professional Services

MEDIA:

Photo
Photo
Aramark Correctional Services is celebrating the 20th anniversary of its IN2WORK (I2W) program, a milestone in the journey of working with thousands of justice-impacted individuals, offering education and industry certifications for a path to success both during and post-incarceration.
Logo
Logo

Sapiens Introduces Next-Generation Enhancements for Life & Annuities Insurers with Updated IllustrationPro and ApplicationPro

PR Newswire


Latest releases elevate automation, risk intelligence, and customization to drive seamless policy management and superior agent experience


ROCHELLE PARK, N.J.
, April 2, 2025 /PRNewswire/ — Sapiens International Corporation (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced the latest release of Sapiens IllustrationPro and Sapiens ApplicationPro, which deliver cutting-edge enhancements designed to meet the evolving needs of insurers. Driven by industry trends and direct user feedback, the updates provide greater automation, risk intelligence, and operational efficiency to transform how agents and advisors illustrate policies to applicants, manage business users, and integrate with underwriting and sales platforms, optimizing the agent/advisor experience.

Sapiens Logo

As part of the new release, Sapiens IllustrationPro for Life & Annuities – a recipient of Celent’s prestigious Luminary Award and two XCelent Awards – takes illustration capabilities to the next level. This update provides insurers with unprecedented flexibility, control, and intelligence in managing illustrations and integrating with underwriting and sales platforms. Advanced solve capabilities allow for greater customization of premium and face amount searches, and a powerful new Report Editor enables effortless modifications to reports without IT intervention. Enhanced APIs and deep-linking functionality streamline workflows, ensuring a seamless and connected experience for agents and advisors.

With the latest release of ApplicationPro for Life & Annuities, insurers benefit from a more streamlined, compliant, and user-friendly process that enhances automation, risk assessment, and policy change management. New features such as Manager Review for oversight and compliance, AI-driven risk detection, and seamless API integrations empower insurers to accelerate underwriting, reduce errors, and improve agent efficiency. The upgraded user management interface simplifies administration, eliminating manual configurations and offering real-time access to application data.

“By continuously evolving our solutions, we enable insurers to meet market demands with agility, efficiency, and confidence,” said Roni Al-Dor, President and CEO of Sapiens. “The latest releases of IllustrationPro and ApplicationPro reinforce our commitment to innovation, providing insurers with the tools to drive superior agent and customer experiences while optimizing their operations.”

Both solutions are now available, empowering insurers to modernize their digital ecosystems and enhance operational performance.


Sapiens IllustrationPro
 is an award-winning, cloud-based illustration and quoting solution that delivers a fast, intuitive experience for advisors. Powered by a robust calculation engine, it supports complex new business and in-force illustrations with a library of more than 4,500 calculations for life, health, and annuity insurance.


Sapiens ApplicationPro
 is an award-winning, web-based eApp solution available as a modular, standalone system or seamlessly integrated with Sapiens Insurance Platform. It enhances efficiency by reducing time-to-issue, eliminating Not in Good Order (NIGO) applications, and lowering policy acquisition costs.

About Sapiens 

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a global leader in intelligent insurance SaaS-based software solutions. With Sapiens’ robust platform, customer-driven partnerships, and rich ecosystem, insurers are empowered to future-proof their organizations with operational excellence in a rapidly changing marketplace. Our SaaS- based Solutions help insurers harness the power of AI and advanced automation to support core solutions for property and casualty, workers’ compensation, and life insurance, including reinsurance, financial & compliance, data & analytics, digital, and decision management. Sapiens boasts a longtime global presence, serving over 600 customers in more than 30 countries with its innovative offerings. Recognized by industry experts and selected for the Microsoft Top 100 Partner program, Sapiens is committed to partnering with our customers for their entire transformation journey and is continuously innovating to ensure their success. For more information visit https://sapiens.com or follow us on LinkedIn

Investor and Media Contact :
Yaffa Cohen-Ifrah
Sapiens Chief Marketing Officer and Head of Investor Relations
Email: [email protected] 

Forward Looking Statements

Certain matters discussed in this press release that are incorporated herein and therein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to:  the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; the global macroeconomic environment, including headwinds caused by inflation, relatively high interest rates, potentially unfavorable currency exchange rate movements, and uncertain economic conditions, and their impact on our revenues, profitability and cash flows; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers’ systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the coronavirus epidemic,  and fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company.

While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2023, to be filed in the near future, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

Logo: http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

 

Cision View original content:https://www.prnewswire.com/news-releases/sapiens-introduces-next-generation-enhancements-for-life–annuities-insurers-with-updated-illustrationpro-and-applicationpro-302418428.html

SOURCE Sapiens International Corporation

Defiance Launches $GLDY, Gold Enhanced Options Income ETF

MIAMI, April 02, 2025 (GLOBE NEWSWIRE) — Defiance ETFs is proud to announce the launch of GLDY, the Defiance Gold Enhanced Options Income ETF. GLDY offers investors a new opportunity to seek current income while gaining indirect exposure to the price movements of physical gold bullion.

“We’re excited to introduce GLDY,” said Sylvia Jablonski, CEO of Defiance ETFs. “With GLDY, investors can access enhanced income potential tied to the price of gold—a historically resilient asset in times of economic uncertainty. As central banks continue to manage inflation and global instability persists, gold may remain a sought-after safe haven.”

GLDY is an actively managed ETF designed to provide income while maintaining indirect exposure to the share price performance of GLD, which seeks to track the price of physical gold bullion.

The Fund’s strategy focuses on having the ability to make monthly distributions through generating income throughout each week by regularly selling put options. Simultaneously, it aims to provide an “enhanced” yield compared to traditional option-based strategies by frequently selling short-term options, typically with a duration of less than a week.

An Investment in the Fund is not an investment in GLD, nor in gold bullion. The Fund’s strategy will cap its potential options income gains if GLD shares increase in value. The Fund’s strategy is subject to all potential losses if GLD shares decline, which may not be offset by income received by the Fund. ● The Fund does not invest directly in GLD shares. ● The Fund does not invest directly in gold bullion. ● Fund shareholders are not entitled to any dividends paid by GLD.

There is no guarantee that the Fund’s investment strategy will be properly implemented, and an investor may lose some or all of its investment.

About Defiance ETFs

Founded in 2018, Defiance is at the forefront of ETF innovation. Defiance is a leading ETF issuer specializing in thematic, income, and leveraged ETFs.

Important Disclosures

GLDY Disclosure: Defiance ETFs LLC is the ETF sponsor. The Fund’s investment adviser is Tidal Investments, LLC (“Tidal” or the “Adviser”).

Fund holdings and sector allocations are subject to change at any time and should not be considered recommendations to buy or sell any security.

The Funds’ investment objectives, risks, charges, and expenses must be considered carefully before investing. The prospectus contains this and other important information about the investment company. Please read carefully before investing. A hard copy of the prospectuses can be requested by calling 833.333.9383.

GLD is an exchange-traded product (“ETP”) that generally seeks to replicate the performance of the price of gold bullion. GLD is not subject to the protections of the1940 Act; however, the Fund and its shareholders are subject to the protections of the 1940 Act.

Investing involves risk. Principal loss is possible. As an ETF, the funds may trade at a premium or discount to NAV. Shares of any ETF are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. A portfolio concentrated in a single industry or country, may be subject to a higher degree of risk.

Derivatives Risk. Derivatives are financial instruments that derive value from the underlying reference asset or assets, such as stocks, bonds, or funds (including ETFs and ETPs), interest rates or indexes. The Fund’s investments in derivatives may pose risks in addition to, and greater than, those associated with directly investing in securities or other ordinary investments, including risk related to the market, imperfect correlation with underlying investments, higher price volatility, lack of availability, counterparty risk, liquidity, valuation and legal restrictions.

Counterparty Risk. The Fund is subject to counterparty risk by virtue of its investments in options contracts. Transactions in some types of derivatives, including options, are required to be centrally cleared (“cleared derivatives”). In a transaction involving cleared derivatives, the Fund’s counterparty is a clearing house rather than a bank or broker. Since the Fund is not a member of clearing houses and only members of a clearing house (“clearing members”) can participate directly in the clearing house, the Fund will hold cleared derivatives through accounts at clearing members. If the Fund cannot find a clearing member to transact with on the Fund’s behalf, the Fund may be unable to effectively implement its investment strategy.

GLD Risk. The Fund invests in options contracts that are based on the value of GLD. This subjects the Fund to certain of the same risks as if it owned shares of GLD, even though it does not. By virtue of the Fund’s investments in options contracts that are based on the value of GLD, the Fund may also be subject to the following risks:
GLD Trading Risk. An investment in GLD is subject to substantial risks, in particular risks associated with investing in the gold market. GLD is subject to market fluctuations influenced by large-scale gold sales, especially during economic crises, which can adversely impact gold prices and, in turn, the investment value of the Shares.
Options Contracts. The use of options contracts involves investment strategies and risks different from those associated with ordinary portfolio securities transactions. The prices of options are volatile and are influenced by, among other things, actual and anticipated changes in the value of the underlying instrument, including the anticipated volatility, which are affected by fiscal and monetary policies and by national and international political, changes in the actual or implied volatility or the reference asset, the time remaining until the expiration of the option contract and economic events.

Price Participation Risk. The Fund employs an investment strategy that includes the sale of in-the-money put option contracts, which limits the degree to which the Fund will participate in increases in value experienced by the Underlying ETP over the Call Period (typically, one week, but may range from one day to a month). This means that if the Underlying ETP experiences an increase in value above the strike price of the sold put options during a Call Period, the Fund will likely not experience that increase to the same extent and may significantly underperform the Underlying ETP over the Call Period.

Non-Diversification Risk. Because the Fund is “non-diversified,” it may invest a greater percentage of its assets in the securities of a single issuer or a smaller number of issuers than if it was a diversified fund. As a result, a decline in the value of an investment in a single issuer or a smaller number of issuers could cause the Fund’s overall value to decline to a greater degree than if the Fund held a more diversified portfolio. This may increase the Fund’s volatility and cause the performance of a relatively smaller number of issuers to have a greater impact on the Fund’s performance.

None of the Fund, the Trust, the Adviser, the Sub-Adviser, or their respective affiliates makes any representation to you as to the performance of the Index. THE FUND, TRUST, ADVISER, AND SUB-ADVISER ARE NOT AFFILIATED WITH, NOR ENDORSED BY, THE INDEX.

New Fund Risk: The Fund is a recently organized management investment company with no operating history. As a result, prospective investors do not have a track record or history on which to base their investment decisions.

No 1940 Act Protections: The Underlying ETP is not an investment company subject to the 1940 Act. Accordingly, investors in the Underlying ETP do not have the protections expressly provided by that statute.

An Investment in the Fund is not an investment in GLD, nor in gold bullion.

Diversification does not ensure a profit nor protect against loss in a declining market.

Commissions may be charged on trades.

Distributed by Foreside Fund Services, LLC.

David Hanono
[email protected]
833.333.9383

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cc837cb4-3fe0-4e7a-9928-d88f19d2e1a6



Domino’s® and DoorDash Announce Partnership: World’s Largest Pizza Company to Join Largest Local Commerce Platform in North America

PR Newswire

Orders on DoorDash’s Marketplace will be delivered by Domino’s drivers

Partnership Highlights:

  • Domino’s Joins DoorDash Marketplace: Nationwide U.S. launch beginning in May 2025, expanding to Canada later in 2025
  • Seamless Integration with Self-Delivery: Domino’s drivers fulfill orders while tapping into DoorDash’s leading local commerce platform for new customer reach


ANN ARBOR, Mich. and SAN FRANCISCO
, April 2, 2025 /PRNewswire/ — Domino’s Pizza Inc. (Nasdaq: DPZ), the largest pizza company in the world, has entered into a partnership with DoorDash (Nasdaq: DASH), the leading local commerce platform in North America.1 The partnership will allow Domino’s to reach new customers through DoorDash Marketplace, while continuing delivery service by Domino’s drivers. A pilot is currently underway in select locations, with a planned nationwide U.S. launch beginning in May 2025 and across Canada later in 2025.

A pilot is currently underway in select locations, with a planned nationwide U.S. launch beginning in May 2025.

“As brands that are both dedicated to digital ordering excellence, our new partnership with DoorDash brings together the scale of our two industry-leading companies, as we continue to build towards the $1 billion opportunity that we believe the aggregator marketplace represents for us,” said Joe Jordan, Domino’s chief operating officer and president – U.S. “The ability to connect seamlessly with DoorDash customers means more sales for Domino’s stores, while efficiently leveraging our brand’s robust delivery network. Tapping into incremental customers, particularly in suburban and rural markets, is a meaningful opportunity for Domino’s, as our brand continues to open stores nationwide.”

“DoorDash is excited to welcome Domino’s to our Marketplace across the U.S. and Canada. Domino’s chose DoorDash for our unmatched scale and reach, helping them serve millions of customers and drive incremental sales,” said Prabir Adarkar, president and chief operating officer of DoorDash. “By joining forces, we’re bringing customers a new choice in the rapidly growing pizza category.”

A top-tier delivery and digital experience is core to both companies’ DNA. DoorDash users will be able to order from their local Domino’s store through the DoorDash app, with seamless GPS tracking fully integrated to monitor their delivery progress by a uniformed Domino’s driver. Domino’s orders will be available to subscribers of DashPass, DoorDash’s subscription program, which offers unlimited $0 delivery fees and reduced service fees on orders over $12.2 Domino’s loyalty program, Domino’s Rewards, will only be offered on Domino’s e-commerce platforms.

About Domino’s Pizza®

Founded in 1960, Domino’s Pizza is the largest pizza company in the world, with a significant business in both delivery and carryout. It ranks among the world’s top public restaurant brands with a global enterprise of more than 21,300 stores in over 90 markets. Domino’s had global retail sales of over $19.1 billion in 2024. Its system is comprised of independent franchise owners who accounted for 99% of Domino’s stores as of the end of the fourth quarter of 2024. In the U.S., Domino’s generated more than 85% of U.S. retail sales in 2024 via digital channels and has developed many innovative ordering platforms.

Order – dominos.com
Company Info – biz.dominos.com
Media Assets – media.dominos.com

About DoorDash
DoorDash (NASDAQ: DASH) is a technology company that connects consumers with their favorite local businesses in more than 30 countries across the globe. Founded in 2013, DoorDash builds products and services to help businesses innovate, grow, and reach more customers. DoorDash is your door to more: the local commerce platform dedicated to enabling merchants to thrive in the convenience economy, giving consumers access to more of their communities, and providing work that empowers.

Forward-Looking Statements
This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events, and such statements in this communication include, but are not limited to, expectations regarding the opportunity and expected benefits of the Domino’s and DoorDash partnership and the expected plans for the launch and expansion of such partnership. Expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. For information on potential risks and uncertainties that could cause actual results to differ from any results predicted, please see Domino’s Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and DoorDash’s Annual Report on Form 10-K for the year ended December 31, 2024, each filed with the Securities and Exchange Commission.


1
 Based on total delivery GOV in 2024


2
 *DashPass benefits apply only to eligible orders that meet the minimum subtotal requirement listed on DoorDash for each participating merchant. Other fees (including service fee), taxes, and gratuity still apply. After signing up for DashPass, you will be charged the then-current renewal price (plus applicable taxes) automatically on a recurring basis until you cancel. DashPass terms (including how to cancel) here.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dominos-and-doordash-announce-partnership-worlds-largest-pizza-company-to-join-largest-local-commerce-platform-in-north-america-302417862.html

SOURCE Domino’s Pizza

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

PR Newswire

Providers in the United States may now order the
FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to screening by enabling discreet self-collection

Quest also plans to make self-collection option available at its 2,000 patient service centers in the United States early next month, expanding access to screening

New solution follows company’s launch of GTI self-collection option for several STIs and related conditions last fall


SECAUCUS, N.J.
, April 2, 2025 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who are at risk of developing cervical cancer.

Physicians can now offer patients the option to collect their own specimen for HPV screening in a physician’s office or other healthcare setting. The company also plans to introduce the self-collection option for patients, with a physician’s order, at its 2,000 Quest patient service centers nationwide early next month. The new option builds on Quest’s experience in providing patients with discrete self-collection options. The company introduced a self-collection service option for vaginitis and other genital tract infections, such as chlamydia, gonorrhea, trichomoniasis and Mycoplasma genitalium, at its patient service centers in October 2024, and has experienced strong demand for the solution since the launch.

The new offering utilizes the FDA-cleared HPV self-collection solution from Roche (SIX: RO, ROG; OTCQX: RHHBY), approved for use with Roche’s cobas® HPV test in May 2024. Interested patients can opt for self-collection in clinical settings, such as a doctor’s office, or other healthcare settings.

“We are seeing more demand for solutions that empower patients to take an active role in their health care,” said Kathleen Valentine, Vice President and General Manager of Women’s and Reproductive Health Services at Quest Diagnostics. “Cervical cancer is highly preventable when detected early, and yet, over 4,000 American women will die this year of cervical cancer primarily due to inadequate screening. Our goal is to make HPV screening more accessible and discreet for women who may otherwise skip or delay this vital preventive care test and therefore increase their risk of developing cervical cancer.”

The solution is not FDA approved for at-home collection, and self-collection is not intended to replace a pelvic examination provided by a clinician. Patients should inform their healthcare provider if they suspect they are pregnant or if they have recently had symptoms of pelvic inflammatory disease (such as pelvic pain, pain with sexual intercourse, unusual vaginal discharge or bad odor). If the patient cannot self-collect a specimen, then collection should be performed in another healthcare setting, like a physician’s office, where greater support can be provided. The self-collection option is available at no extra charge for the patient or health plan.


Improving access to reduce cervical cancer incidence 

When testing for HPV in conventional practice, a healthcare provider collects a specimen from a patient in their office or clinic and forwards it to a laboratory for testing. With the new self-collection service, patients may self-collect from their vagina in a private room at a physician’s office using a simple step-by-step guide.1 The provider will send the specimen to a nearby Quest Diagnostics testing laboratory. After testing, results will be provided to the physician and patient electronically. The physician may review the results during a separate patient visit and provide further evaluation as needed.

“The most reliable cervical cancer method is co-testing, which combines HPV and Pap testing, on a specimen collected by a skilled physician,” said board-certified obstetrician and gynecologist Damian P. Alagia, MD, Senior Medical Director, Women’s Health, Quest Diagnostics. “Yet, the reality is that some patients, whether due to stigma, trauma or some other factor, are not comfortable undergoing specimen collection by their OBGYN or other doctor. Giving providers and patients options is important for caring for the needs and interests of the individual patient.”

Historically, ensuring routine cervical cancer screening has been challenging, with 4.4 million fewer American women receiving screenings in 2021 when compared to 2019.2 Incidence of cervical cancer in women aged 30-44 increased 1.7% over the same time.3 Recent draft guidelines from the United States Preventive Services Task Force (USPSTF) on cervical cancer screening states self-collection for HPV screening “has similar accuracy to clinician-collected tests and is associated with increased screening in underscreened individuals and in historically underscreened populations.”4

Quest Diagnostics is a leader in women’s and reproductive health, which includes a complete menu of solutions for screening for and diagnosing cervical cancer. For more information, visit www.QuestWomensHealth.com.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world’s largest databases of de-identifiable clinical lab results, Quest’s diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

______________________


1 Collection directions will be provided for self-collections; however, some patients may experience difficulty with self-collection and may require a visit to their healthcare provider to assist with the collection.


2 Star J, Bandi P, Siegel RL, et al. Cancer screening in the United States during the second year of the COVID-19 pandemic. J Clin Oncol. 2023;41(27). doi:10.1200/JCO.22.0217


3 American Cancer Society. Key statistics for cervical cancer. June 28, 2024. Accessed December 20, 2024. https://www.cancer.org/cancer/types/cervical-cancer/about/key-statistics.html


4
Draft Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-introduces-hpv-specimen-self-collection-for-cervical-cancer-screening-302417788.html

SOURCE Quest Diagnostics

Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) — Marex Group plc (Nasdaq: MRX) (‘Marex’), the diversified global financial services platform, provides a Q1 trading update at its Investor Day, being held today at the Nasdaq Marketsite in New York City.

Marex reports a strong start to the year with positive momentum and supportive market conditions continuing through the first quarter of 2025. Client activity has remained strong across the platform with high levels of exchange volumes driven by volatility. Agency and Execution has benefited from strong performance in the Prime Services business and continued progress in the Energy business.

As a result, first quarter 2025 revenues are expected to be in a range of $449.3 to $464.3 million (Q1 2024: $365.8 million) and Adjusted Profit Before Tax2 in a range of $92.3 to $97.3 million (Q1 2024: $67.7 million).

Ian Lowitt, CEO, stated: “Very robust levels of client activity across our businesses and positive market conditions have continued into 2025 and led to a strong performance in the first quarter of the year, building on our performance in 2024. These benefits more than outweighed the impact of lower net interest income partly arising from the interest rate environment, compared to the fourth quarter of 2024. This demonstrates the successful execution of our strategy to diversify our business and deliver sustainable growth through a variety of market conditions by expanding our geographic footprint and product capabilities, increasing our relevance to a growing client base.”

Preliminary Q1 2025 results range

We have not yet completed our closing procedures for the three months ended March 31, 2025. The table below are certain estimated preliminary unaudited financial results for the three months ended March 31, 2025:

  3 Months ended March 31, 2025

1
  3 Months ended March 31, 2024
Unaudited ($m) Estimated Low Estimated High   Actuals
Revenue 449.3 464.3   365.8
Reported Profit Before Tax 94.4 102.1   58.9
Tax 24.5 26.5   15.3
Reported Profit After Tax 69.9 75.6   43.6
Adjusted Profit Before Tax

2
92.3 97.3   67.7
         
Profit After Tax Margin 16% 16%   12%
Adjusted Profit Before Tax Margin2 21% 21%   19%
         
Basic Earnings per Share ($)3 0.94 1.02   0.60
Diluted Earnings per Share ($)3 0.88 0.96   0.56
Adjusted Basic Earnings per Share ($)2,3 0.94 0.99   0.74
Adjusted Diluted Earnings per Share ($)2,3 0.88 0.93   0.69
  1. Figures reflect certain estimated preliminary unaudited financial results for the three months ended March 31, 2025. Estimates represent results that are preliminary and subject to change. Actual results will not be finalized until after we complete our normal quarter-end accounting procedures, including the execution of our internal control over financial reporting. These estimates reflect our management’s best estimate of the impact of events during this quarter.
  2. These are non-IFRS financial measures. See Appendix 1 “Non-IFRS Financial Measures and Key Performance Indicators” for additional information and for a reconciliation of each such IFRS measure to its most directly comparable non-IFRS measure.
  3. Weighted average number of shares have been restated as applicable for the Group’s reverse share split (refer to Appendix 1 for further detail).

Investor Day

Marex is hosting an Investor Day today, April 2, 2025 starting at 9:30am E.T. The event will feature presentations from Marex’s business heads, to provide a greater understanding of Marex’s operations and growth strategy, as well as a question and answer session with senior leadership including Ian Lowitt, CEO, Rob Irvin, CFO and Paolo Tonucci, Chief Strategist and CEO Capital Markets.

An audio livestream of the event will be available under the ‘events and presentations’ section on ir.marex.com. The webcast will also be available for replay, after the completion of the event.

https://edge.media-server.com/mmc/p/qbimzrae/

About Marex Group:

Marex Group plc (NASDAQ: MRX) is a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. The Group provides comprehensive breadth and depth of coverage across four core services: Clearing, Agency and Execution, Market Making and Hedging and Investment Solutions. It has a leading franchise in many major metals, energy and agricultural products, with access to 60 exchanges. The Group provides access to the world’s major commodity markets, covering a broad range of clients that include some of the largest commodity producers, consumers and traders, banks, hedge funds and asset managers. Headquartered in London with more than 40 offices worldwide, the Group has over 2,300 employees across Europe, Asia and the Americas. For more information visit www.marex.com.

Enquiries please contact:

Marex

Investors – Robert Coates

+44 7880 486 329 / [email protected]

Media – Nicola Ratchford, Marex / FTI Consulting US / UK

+ 44 7786 548 889 / [email protected] / +1 919 609 9423 / +44 7776 111 222 | [email protected]

Forward Looking Statements

This press release contains forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including expected outlook regarding Q1 2025 financial results. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions.

These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation: subdued commodity market activity or pricing levels; the effects of geopolitical events, terrorism and wars, such as the effect of Russia’s military action in Ukraine or the on-going conflicts in the Middle East, on market volatility, global macroeconomic conditions and commodity prices; changes in interest rate levels; the risk of our clients and their related financial institutions defaulting on their obligations to us; regulatory, reputational and financial risks as a result of our international operations; software or systems failure, loss or disruption of data or data security failures; an inability to adequately hedge our positions and limitations on our ability to modify contracts and the contractual protections that may be available to us in OTC derivatives transactions; market volatility, reputational risk and regulatory uncertainty related to commodity markets, equities, fixed income, foreign exchange; the impact of climate change and the transition to a lower carbon economy on supply chains and the size of the market for certain of our energy products; the impact of changes in judgments, estimates and assumptions made by management in the application of our accounting policies on our reported financial condition and results of operations; lack of sufficient financial liquidity; if we fail to comply with applicable law and regulation, we may be subject to enforcement or other action, forced to cease providing certain services or obliged to change the scope or nature of our operations; significant costs, including adverse impacts on our business, financial condition and results of operations, and expenses associated with compliance with relevant regulations; and if we fail to remediate the material weaknesses we identified in our internal control over financial reporting or prevent material weaknesses in the future, the accuracy and timing of our financial statements may be impacted, which could result in material misstatements in our financial statements or failure to meet our reporting obligations and subject us to potential delisting, regulatory investments or civil or criminal sanctions, and other risks discussed under the caption “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2024 filed with the Securities and Exchange Commission (the “SEC”) and our other reports filed with the SEC.

The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.

Appendix 1

Non-IFRS Financial Measures and Key Performance Indicators

In addition to our results determined in accordance with IFRS Accounting Standards (IFRS), we believe the following non-IFRS measures provide useful information both to management and investors in measuring our financial performance for the reasons outlined below. These measures may not be comparable to similarly titled measures presented by other companies, and they should not be construed as an alternative to other financial measures determined in accordance with IFRS. The Group changed the labelling of its non-IFRS measures during 2024 to simplify the naming to better align to the equivalent IFRS reported metric for better understanding and communication and enhance transparency and comparability.

Adjusted Profit Before Tax (formerly labelled Adjusted Operating Profit)

We define Adjusted Profit Before Tax as profit after tax adjusted for (i) taxation charge (ii) acquisition costs, (iii) bargain purchase gains, (iv) owner fees, (v) amortisation of acquired brands and customer lists, (vi) activities in relation to shareholders, and (vii) IPO preparation costs. Items (i) to (vii) are referred to as “Adjusting Items.” Adjusted Profit Before Tax is an important measure used by our management to evaluate and understand our underlying operations and business trends, forecast future results and determine future capital investment allocations. Adjusted Profit Before Tax is the measure used by our executive board to assess the financial performance of our business in relation to our trading performance and hence it is our segments performance measure presented under IFRS Accounting Standards. Adjusted Profit Before Tax is also presented on a consolidated basis because our management believes it is important to consider our profitability on a basis consistent with that of our operating segments. When presented on a consolidated basis, Adjusted Profit Before Tax is a non-IFRS measure.  The most directly comparable IFRS measure is profit after tax.

Adjusted Profit Before Tax Margin (formerly labelled Adjusted Operating Profit Margin)

We define Adjusted Profit Before Tax Margin as Adjusted Profit Before Tax (as defined above) divided by revenue. We believe that Adjusted Profit Before Tax Margin is a useful measure as it allows management to assess the profitability of our business in relation to revenue. The most directly comparable IFRS Accounting Standards measure is profit margin, which is profit after tax divided by revenue.

Adjusted Profit After Tax Attributable to Common Equity (formerly labelled Adjusted Operating Profit after Tax Attributable to Common Equity)

We define Adjusted Profit After Tax Attributable to Common Equity as profit after tax adjusted for the items outlined in the Adjusted Profit Before Tax paragraph above. Additionally, Adjusted Profit After Tax Attributable to Common Equity is also adjusted for (i) tax and the tax effect of the Adjusting Items to calculate Adjusted Profit Before Tax and (ii) profit attributable to AT1 note holders, which is the coupons on the AT1 issuance and accounted for as dividends adjusted for the tax benefit of the coupons. Common equity is a non-IFRS measure and we define Common Equity as being the equity belonging to the holders of the Group’s share capital.

Adjusted Basic Earnings per Share and Adjusted Diluted Earnings per Share

Adjusted Basic Earnings per Share is defined as the Adjusted Profit After Tax Attributable to Common Equity for the period divided by weighted average number of ordinary shares for the period. We believe Adjusted Basic Earnings per Share is a useful measure as it allows management to assess the profitability of our business per share. The most directly comparable IFRS metric is basic earnings per share. This metric has been designed to highlight the Adjusted Profit After Tax Attributable to Common Equity over the available share capital of the Group. Adjusted Diluted Earnings per Share is defined as the Adjusted Profit After Tax Attributable to Common Equity for the period divided by the diluted weighted average shares for the period. We believe Adjusted Diluted Earnings per Share is a useful measure as it allows management to assess the profitability of our business per share on a diluted basis. Dilution is calculated in the same way as it has been for diluted earnings per share. The most directly comparable IFRS metric is diluted earnings per share.

Reconciliation

The following table reconciles: (1) Adjusted Profit Before Tax and Adjusted Profit after Tax Attributable to Common Equity from the most directly comparable IFRS Accounting Standards measure, which is profit after tax, (2) Adjusted Profit Before Tax Margin from the most directly comparable IFRS Accounting Standards measure, which is profit margin (which is profit after tax divided by revenue), (3) Adjusted Basic Earnings per Share from the most directly comparable IFRS measure, which is basic earnings per share, and (4) Adjusted Diluted Earnings per Share from the most directly comparable IFRS measure, which is diluted earnings per share, in each case, for the periods presented below.

Reconciliation of Non-IFRS Financial Measures and Key Performance Indicators:

  3 months ended March 31, 2025   3 months ended March 31, 2025   3 months ended March 31, 2024
  Estimated Low   Estimated High   Actuals
  $m   $m   $m
Profit After Tax 69.9   75.6   43.6
Taxation charge 24.5   26.5   15.3
Profit Before Tax 94.4   102.1   58.9
Bargain purchase gains1 (3.4)   (6.1)  
Acquisition costs2     0.2
Amortisation of acquired brands and customer lists3 1.3   1.3   0.8
Activities relating to shareholders4     2.4
Owner fees5     1.7
IPO preparation costs6     3.7
Adjusted Profit Before Tax 92.3   97.3   67.7
Tax and the tax effect on the Adjusting Items7 (22.8)   (24.1)   (15.5)
Profit attributable to AT1 note holders8 (3.3)   (3.3)   (3.3)
Adjusted Profit after Tax Attributable to Common Equity 66.2   69.9   48.9
           
Profit After Tax Margin 16%   16%   12%
Adjusted Profit Before Tax Margin

9
21%   21%   19%
           
Basic Earnings per Share ($)

10
0.94   1.02   0.60
Diluted Earnings per Share ($)

1


1
0.88   0.96   0.56
           
Adjusted Basic Earnings per Share($)

10
0.94   0.99   0.74
Adjusted Diluted Earnings per Share ($)

1


1
0.88   0.93   0.69
           
  1. A bargain purchase gain is expected to be recognised as a result of the Group’s acquisition of Darton Group Limited.
  2. Acquisition costs are costs, such as legal fees incurred in relation to the business acquisitions.
  3. This represents the amortisation charge for the period of acquired brands and customers lists.
  4. Activities in relation to shareholders primarily consist of dividend-like contributions made to participants within certain of our share-based payments schemes.
  5. Owner fees relate to management services fees paid to parties associated with the ultimate controlling party based on a percentage of our EBITDA in each year, presented in the income statement within other expenses.
  6. IPO preparation costs related to consulting, legal and audit fees, presented in the income statement within other expenses.
  7. Tax and the tax effect on the Adjusting Items represents the tax for the period and the tax effect of the other Adjusting Items removed from Profit After Tax to calculate Adjusted Profit Before Tax. The tax effect of the other Adjusting Items was calculated at the Group’s effective tax rate for the respective period.
  8. Profit attributable to AT1 note holders are the coupons on the AT1 issuance, which are accounted for as dividends.
  9. Adjusted Profit Before Tax Margin is calculated by dividing Adjusted Profit Before Tax (as defined above) divided by revenue for the period.
  10. The weighted average numbers of shares used in the calculation for the three months ended March 31, 2025 range estimates and three months ended March 31, 2024 actuals were 70,541,771 and  65,683,374 respectively.  Weighted average number of shares have been restated as applicable for the Group’s reverse share split.
  11. The weighted average numbers of diluted shares used in the calculation for the three months ended March 31, 2025 range estimates and three months ended March 31, 2024 actuals were 74,942,291 and  70,383,309 respectively.  Weighted average number of shares have been restated as applicable for the Group’s reverse share split.



Cartesian Therapeutics Announces New Employment Inducement Grants

FREDERICK, Md., April 02, 2025 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapies for the treatment of autoimmune diseases, today announced the granting of inducement awards to four new employees. On April 1, 2025, the Company issued to these employees options to purchase an aggregate of 31,000 shares of the Company’s common stock with an exercise price of $12.49, the closing trading price of the Company’s common stock on the Nasdaq Global Market on the date of grant. The options were granted pursuant to the Company’s Amended and Restated 2018 Employment Inducement Incentive Award Plan and were approved by the Company’s board of directors. The options vest as to 25% on April 1, 2026, and then in three equal annual installments thereafter such that the options will be fully vested on April 1, 2029. The options have a ten-year term. The options were granted under Rule 5635(c)(4) of the Nasdaq Listing Rules as an inducement material to the employees’ entry into employment with the Company.

About Cartesian Therapeutics

Cartesian Therapeutics is a clinical-stage company pioneering cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T entering Phase 3 clinical development for patients with generalized myasthenia gravis and Phase 2 development for systemic lupus erythematosus, with a Phase 2 basket trial planned in additional autoimmune indications. A Phase 3 trial of Descartes-08 in patients with generalized myasthenia gravis has received written agreement from the FDA under the Special Protocol Assessment process. The Company’s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-BCMA CAR-T currently being evaluated in a Phase 1 trial in patients with multiple myeloma. For more information, please visit www.cartesiantherapeutics.com or follow the Company on LinkedIn or X, formerly known as Twitter.

Contact Information:

Investor Contact:
Megan LeDuc
Associate Director, Investor Relations
[email protected]

Media Contact:
David Rosen
Argot Partners
[email protected]